Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator

Archives of Ophthalmology

Volumn 116, Issue 10, 1998, Pages 1326-1332

  Ohji, Masahito ^a   Saito, Yoshifiiro ^a   Hayashi, Atsushi ^a   Lewis, John M ^b   Tano, Yasuo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Retinal Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAFLUOROPROPANE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CASE REPORT; COMPRESSION THERAPY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETINA FOVEA; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 0031661341     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.10.1326     Document Type: Article

References (25)

1. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33-37.
2. Avery RL, Fekrat S, Hawkins BS, Bressler NM, Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183-189.
3. Saito K, lijima H. Visual prognosis and macular pathology in eyes with retinal macroaneurysms. Nippon Ganka Gakkai Zasshi. 1997;101:148-151.
4. Hanscom TA, Diddie KR. Early surgical drainage of macular subretinal hemorrhage. Arch Ophthalmol. 1987;105:1722-1723.
5. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121:267-275.
6. Ibanez HE, Williams OF, Thomas MA, et al. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol. 1995;113:62-69.
7. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-568.
8. Vander JF, Federman JL, Greven C, Slusher MM, Gabel VP. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology. 1991;98:23-27.
9. de Juan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. 1988;105:25-29.
10. Lim JI, Drews-Botsch C, Sternberg P Jr, Capone A Jr, Aaberg TM Sr. Submacular hemorrhage removal. Ophthalmology. 1995;102:1393-1399.
11. Heriot WJ. Further experience in management of submacular hemorrhage with intravitreal TPA. In: Program and abstracts of Vitreoretinal Update 1997; October 24-25, 1997; San Francisco, Calif, Pages 82-84.
12. Ohji M, Motokura M, Saito Y, Ishimoto I, Tano Y. Vitreous surgery for massive subretinal hemorrhage: evacuation of SRH by peripheral retinotomy, gas tamponade and prone position. In: Program and abstracts of the 34th Annual Meeting of the Vitreoretinal Society of Japan; October 27-28, 1995; Okayama, Japan. 1995;34:98.
13. Parver LM, Lincoff H. Mechanics of intraocular gas. Invest Ophthalmol Vis Sci. 1978;17:77-79.
14. Takebayashi T, Oka T, Tabuchi A. Gas tamponade with sulfur hexafluoride was effective in a case of age-related macular degeneration. Jpn Rev Clin Ophthalmol. 1996;90:1174-1176.
15. Kimura AE, Reddy CV, Folk JC, Farmer SG. Removal of subretinal hemorrhage facilitated by preoperative intravitreal tissue plasminogen activator. Retina. 1994;14:83-84.
16. Coll GE, Sparrow JR, Marinovic A, Chang S. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina. 1995;15:319-326.
17. Williams DF, Han DP, Abrams GW. Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator. Arch Ophthalmol. 1990;108:264-266.
18. Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol. 1991;109:718-722.
19. Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol. 1990;108:259-263.
20. Tani PM. Buettner H, Robertson DM. Massive vitreous hemorrhage and senile macular choroidal degeneration. Am J Ophthalmol. 1980;90:525-533.
21. Hilton GF, Kelly NE. Salzano TC, Tornambe PE, Wells JW, Wendel RT. Pneumatic retinopexy: a collaborative report of the first 100 cases. Ophthalmology. 1987;94:307-314.
22. McAllister IL, Meyers SM, Zegarra H, Gutman FA, Zakov ZN, Beck GJ. Comparison of pneumatic retinopexy with alternative surgical techniques. Ophthalmology. 1988;95:877-883.
23. Algvere P, Hallnas K, Palmqvist BM. Success and complications of pneumatic retinopexy. Am J Ophthalmol. 1988;106:400-404.
24. Tornambe PE, Hilton GF. Pneumatic retinopexy: a multicenter randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling. Ophthalmology. 1989;96:772-783.
25. Campochiaro PA, Jerdan JA, Glaser DM. Serum contains chemoattractants for human pigment epithelial cells. Arch Ophthalmol. 1984;102:1830-1833.